Bringing clinical trials into a community oncology practice no longer requires building a large research department from the ground up. Many practices are expanding trial access through partnerships, shared-care models, and technology that helps identify eligible patients and coordinate care. With the right community oncology practice infrastructure, physicians can offer more research opportunities while continuing to manage the patient relationships they have worked hard to build.
Why Trial Opportunities Are Often Missed in Community Settings
Most community oncologists believe clinical trials should be more accessible to patients. The challenge is not convincing physicians of their value. The challenge is creating a process that works within the reality of a busy oncology practice.
A patient may be clinically eligible for a trial, but eligibility alone does not guarantee participation. Someone must identify the opportunity, evaluate the study requirements, coordinate communication, and determine whether the trial is a good fit for the patient. In many community settings, these steps compete with dozens of other priorities throughout the day.
Some practices have limited staff available to support research-related activities. Others may not have visibility into studies outside their immediate network. There are also situations where trial opportunities are discovered too late because treatment decisions have already been made.
None of these challenges reflects a lack of commitment to patient care. They simply highlight how difficult it can be to integrate research into an environment that is primarily focused on delivering timely treatment.
This is one reason why conversations around community oncology trial participation have shifted in recent years. Instead of asking practices to build traditional research programs, healthcare organizations are exploring ways to bring research opportunities closer to existing clinical workflows.
The Biggest Misconception About Clinical Trial Infrastructure
One of the most common assumptions in oncology is that practices must create a full-scale research department before they can participate in clinical trials.
That approach may work for large institutions, but it is not the only option. In fact, many community practices successfully support research activities without operating a dedicated research division.
The more important question is not how many people a practice employs. It is whether physicians and staff have access to the right tools, processes, and support when an opportunity arises.
This shift in thinking has changed the conversation around trial infrastructure for community practice settings. Instead of focusing entirely on internal resources, many organizations are evaluating how external partnerships can help fill operational gaps.
For example, a practice may not have a full-time research coordinator, but it may have access to a partner that provides coordination support. Another practice may not manage trial matching internally, yet still connect patients with appropriate studies through an external platform.
When viewed this way, infrastructure becomes less about building everything yourself and more about creating reliable pathways for patient access.
Building a Process Instead of Building a Research Department
Practices interested in research participation often start by asking what they need to add. A more useful question may be what they already have.
Most community oncology practices already possess many of the ingredients needed to support clinical trial access. They have physician expertise, patient relationships, clinical workflows, and established care teams. The challenge is organizing these strengths into a process that consistently identifies and evaluates opportunities.
A strong community oncology practice infrastructure typically includes:
- A process for identifying potentially eligible patients
- Clear communication among physicians, staff, and external partners
- Defined workflows for evaluating research opportunities
- Access to trial information and referral resources
- Systems that support patient follow-up and coordination
These capabilities do not need to be overly complex. In many cases, small improvements in communication and workflow design can make a meaningful difference.
The goal is not to turn every practice into a research center. The goal is to make research access a practical part of everyday oncology care.
Explore Community Oncology Growth Strategy Solutions
Where Small Practices Usually Get Stuck
Smaller practices often face a different set of challenges than larger organizations.
In some cases, there may only be a handful of staff members managing scheduling, patient communication, and administrative responsibilities. Adding research-related tasks can feel unrealistic when existing teams are already operating at capacity.
There is also the question of consistency. A physician may identify an eligible patient today, but without a clear process, that opportunity may not be captured again next week.
Another common challenge involves uncertainty around available resources. Some practices assume they need to solve every operational issue before they can participate in research. As a result, they postpone discussions that could have started much earlier.
The reality is that many successful programs begin with modest goals. Rather than launching multiple studies at once, practices focus on creating a repeatable process that can grow over time.
This approach often leads to more sustainable results because it allows teams to build confidence while maintaining focus on patient care.
The Role of Shared Care in Keeping Physicians Connected
One concern that surfaces frequently in discussions about clinical trials is the fear of losing continuity of care.
Community oncologists spend years building relationships with patients and families. It is understandable that they want to remain involved when additional treatment options are being considered.
Historically, some referral models created separation between providers. Once a patient entered a research program, communication between organizations could become inconsistent. Community physicians sometimes felt disconnected from treatment decisions that affected their patients.
Shared-care models are helping address this issue.
Instead of positioning clinical trials as a transfer of care, these models encourage collaboration among providers. Community physicians remain part of the conversation while specialists contribute expertise related to specific studies or treatment approaches.
This framework is becoming an important answer to the question, How can community oncology offer clinical trials while preserving established physician-patient relationships.
Organizations such as 1104Health have embraced this collaborative approach because it reflects how many physicians prefer to practice. Patients gain access to additional resources while community providers remain engaged throughout the process.
Where Technology Fits Into the Process
Technology is often discussed as if it can solve every challenge associated with research participation. In reality, technology works best when it supports a well-designed process.
One area where technology can provide immediate value is patient identification. Clinical trial opportunities are frequently time-sensitive. If a patient is not identified at the appropriate stage of treatment, that opportunity may disappear.
An effective oncology technology platform helps practices improve visibility into available studies and streamline communication among care teams. This reduces the amount of manual effort required to evaluate opportunities and coordinate next steps.
Technology can also support collaboration among physicians, specialists, and coordinators who may be working across multiple organizations.
Still, technology should not replace clinical judgment or physician relationships. The most successful programs use technology as a support tool rather than the center of the strategy.
Why Decentralized Research Is Gaining Attention
Over the last several years, more healthcare organizations have started exploring decentralized oncology research infrastructure as a way to improve access to clinical trials.
The reason is simple. Many patients receive treatment close to home and prefer to continue doing so whenever possible.
Traditional research models often require frequent travel to larger institutions. While some patients can manage these demands, others face transportation challenges, scheduling limitations, or personal circumstances that make participation difficult.
Decentralized approaches attempt to remove some of those barriers by allowing portions of research activities to occur within community settings.
This does not eliminate the role of academic centers or research institutions. Instead, it creates a more connected system where different organizations contribute based on their strengths.
For community practices, decentralized models create opportunities to support community oncology trial participation without assuming every responsibility associated with managing a study independently.
Why Regional Relationships Matter
Research participation is often influenced by relationships that exist long before a patient is evaluated for a trial.
Physicians who know one another tend to communicate more effectively. Organizations that have established referral pathways often coordinate care more efficiently. These relationships become especially important when patients require specialized expertise or access to emerging therapies.
This is why regional oncology collaboration continues to receive attention across the healthcare industry.
Strong regional networks create opportunities for practices to share knowledge, improve communication, and expand access to treatment options. They also help reduce the isolation that some community providers experience when trying to navigate research opportunities independently.
In many cases, the strength of a network has a direct impact on how easily patients can access clinical trials.
Understanding the Oncology Network Partnership Model
An oncology network partnership model is not simply a referral arrangement. At its best, it creates an environment where physicians can work together while maintaining continuity of care.
Common advantages include:
- Access to broader clinical trial opportunities
- Improved communication among providers
- Additional support for patient navigation
- Greater visibility into treatment options
- Stronger coordination throughout the patient journey
These partnerships are becoming increasingly valuable for practices pursuing independent oncology practice clinical trials because they help bridge operational and resource gaps.
Rather than requiring practices to build every capability internally, network partnerships create access to expertise that may already exist elsewhere within the healthcare ecosystem.
Connect With 1104Health to Expand Clinical Trial Access
Making Clinical Trial Access Part of Everyday Oncology Care
One of the most effective ways to increase trial participation is to stop treating clinical research as a separate activity.
When research discussions occur only occasionally, opportunities are easier to miss. When trial evaluation becomes part of routine patient conversations, identifying eligible candidates becomes much more consistent.
This does not mean every patient will enroll in a study. It simply means that research opportunities are considered alongside other treatment options when appropriate.
Practices that successfully integrate clinical trials into everyday workflows often find that participation becomes more manageable over time. Physicians become more familiar with available resources, staff develop confidence in established processes, and communication improves across the care team.
Organizations such as 1104Health are helping practices move in this direction by supporting models that connect research access with routine oncology care rather than treating the two as separate systems.
Frequently Asked Questions
1. What is community oncology practice infrastructure?
Community oncology practice infrastructure refers to the systems, workflows, technology, partnerships, and operational resources that help oncology practices deliver care and support clinical trial participation.
2. How can community oncology offer clinical trials?
Community oncology practices can offer clinical trials through collaborative care models, network partnerships, technology platforms, and external support resources that help connect patients with appropriate studies.
3. What is decentralized clinical trial infrastructure?
Decentralized clinical trial infrastructure allows portions of research activities to take place closer to where patients receive care, reducing barriers associated with traditional centralized trial models.
4. How do regional oncology networks share patients?
Regional oncology networks typically use coordinated care models that allow physicians and specialists to collaborate while maintaining communication and continuity of care throughout the treatment process.
5. What does value-based oncology care mean?
Value-based oncology care focuses on improving outcomes, strengthening care coordination, and delivering high-quality treatment experiences while using healthcare resources effectively.
